Skip Navigation

A Phase II Basket Trial of Glutaminase Inhibitor BeGIN CB- 839 HCl in Patients with NF1 Aberrations, NF1 Mutant Malignant Peripheral Nerve Sheath Tumors MPNST, KEAP1/NRF2 and LKB1 Aberrant Tumors

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03872427

Study #:
STUDY00146239

Start Date:
Nov 18, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03872427

View Complete Trial Details & Eligibility at ClinicalTrials.gov